<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Cohen, Deborah J.</style></author><author><style face="normal" font="default" size="100%">Sweeney, Shannon M.</style></author><author><style face="normal" font="default" size="100%">Springer, Rachel</style></author><author><style face="normal" font="default" size="100%">Balasubramanian, Bijal A.</style></author><author><style face="normal" font="default" size="100%">Michaels, LeAnn</style></author><author><style face="normal" font="default" size="100%">Marino, Miguel</style></author><author><style face="normal" font="default" size="100%">Hessler, Danielle</style></author><author><style face="normal" font="default" size="100%">Baron, Andrea</style></author><author><style face="normal" font="default" size="100%">Nesse, Johanna</style></author></authors><secondary-authors></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Intervention to Improve Psychosocial Care for People with Type 2 Diabetes</style></title><secondary-title><style face="normal" font="default" size="100%">The Journal of the American Board of Family
                Medicine</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2025</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2025-03-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">253-274</style></pages><doi><style  face="normal" font="default" size="100%">10.3122/jabfm.2024.240265R1</style></doi><volume><style face="normal" font="default" size="100%">38</style></volume><issue><style face="normal" font="default" size="100%">2</style></issue><abstract><style  face="normal" font="default" size="100%">Background: This proof-of-concept study tested the feasibility and acceptability of INTEGRATE-D, an implementation support intervention for primary care clinics to improve the psychosocial care of patients with type 2 diabetes.Methods: Cluster randomized controlled pragmatic trial, with a parallel, convergent mixed methods design. Two Intervention Clinics (ICs) were offered tailored training on American Diabetes Association (ADA)-recommended psychosocial care and facilitation to identify and support clinical change. Two Control Clinics (CCs) received no intervention. Primary outcomes: intervention acceptability, appropriateness and feasibility. Secondary outcomes: process-of-care metrics (eg, depression screening, diabetes management) and clinical outcomes measures (PHQ-9 and A1C). Qualitative data were collected to assess implementation and experience with the intervention.Results: ICs were offered training and received 15-months of facilitation. To accommodate COVID-19-related safety restrictions, the intervention was changed to be delivered virtually (eg, remote facilitation and training sessions). Despite an adapted delivery and COVID-19 and staffing stressors, clinics exposed to INTEGRATE-D found it to be acceptable, well-aligned with clinics’ needs, and feasible. Qualitative data suggest COVID-19 stressors tempered feasibility. The effect of INTEGRATE-D on process and clinical outcome measures were mixed. Several factors, including differences in ICs and CCs not addressed in randomization and delivery of a less intensive intervention due to the pandemic, may help explain these results.Conclusions: Given the growing number of people with type 2 diabetes and the importance of psychosocial care for these patients, INTEGRATE-D warrants further pilot-testing with a larger sample of clinics and patients, and under conditions where in-person facilitation and expanded training is possible.</style></abstract></record></records></xml>